A Comparison between Islet and Stem Cell Transplantation for T1DM - Sugianto, Astrid Indrafebrina;Sandrin, Mauro;Ierino, Frank
23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
  • Broschiertes Buch

The incidence of Type 1 Diabetes Mellitus (T1DM) has been increasing rapidly worldwide, while the current standard therapy - exogenous insulin supply - is considered unsustainable and highly associated with poor glycemic control that may lead to a life-threatening condition. On the other hand, cellular-based therapy including either islet cell or stem cell transplantation has been recently developed, making it pertinent to compare the effectiveness between the two alternative treatments. The aim of this systematic review is to compare the safety and effectiveness between islet cell…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The incidence of Type 1 Diabetes Mellitus (T1DM) has been increasing rapidly worldwide, while the current standard therapy - exogenous insulin supply - is considered unsustainable and highly associated with poor glycemic control that may lead to a life-threatening condition. On the other hand, cellular-based therapy including either islet cell or stem cell transplantation has been recently developed, making it pertinent to compare the effectiveness between the two alternative treatments. The aim of this systematic review is to compare the safety and effectiveness between islet cell transplantation and stem cell transplantation for future practice change.
Autorenporträt
A.I. Sugianto ist eine 22-jährige Medizinstudentin mit einem Bachelor of Medical Science der Universität Melbourne. 2013 wurde sie vom britischen Ministerium für Wirtschaft und Arbeit als eine der 300 besten jungen Wissenschaftler ausgezeichnet. Außerdem war sie 2014 ehemalige Botschafterin für HPAIR. Sie war an der Brustkrebsforschung beteiligt, bevor sie beschloss, sich auf die Zelltransplantation zu konzentrieren.